Science Explorer Back to mapMap
Discussion
Researcher · Pfizer (Netherlands) · Netherlands

Mark H. Rozenbaum

Mark H. Rozenbaum publishes mostly in Epidemiology, Molecular Biology and Economics and Econometrics, on topics such as Pneumonia and Respiratory Infections, Respiratory viral infections research and Amyloidosis: Diagnosis, Treatment, Outcomes.

ORCID 0000-0001-6209-4370 OpenAlex
World rank
#831,288
of 7,710,434 ranked researchers
Rank in Netherlands
#19,737
of 107,149
Works
119
Citations
2.6k
Citations per work
22.2
h-index
30
i10-index 50Top 10% in Epidemiology
Mark H. Rozenbaum

What does Mark H. Rozenbaum research?

Mark H. Rozenbaum's work is mostly in Medicine (50%), Biochemistry, Genetics and Molecular Biology (7%), Economics, Econometrics and Finance (7%).

Health Sciences: 60 works · 50.4% of their workMedicine: 60 works · 50.4% of their workEpidemiology: 43 works · 36.3% of their workNephrology: 6 works · 5.1% of their workInfectious Diseases: 6 works · 4.8% of their workPulmonary and Respiratory Medicine: 5 works · 4.2% of their workEverything else: 43 works · 35.8% of their workLife Sciences: 9 works · 7.2% of their workBiochemistry, Genetics and Molecular Biology: 9 works · 7.2% of their workMolecular Biology: 9 works · 7.2% of their workSocial Sciences: 8 works · 6.6% of their workEconomics, Econometrics and Finance: 8 works · 6.6% of their workEconomics and Econometrics: 8 works · 6.6% of their workTHEIR WORKMark H. Rozenbaum119works
Life Sciences7%Health Sciences50%Social Sciences7%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine6050.4%
  2. Everything else4335.8%
    1. Biochemistry, Genetics and Molecular Biology97.2%
    1. Economics, Econometrics and Finance86.6%
  1. 1Epidemiology36% of their works
  2. 2Molecular Biology7% of their works
  3. 3Economics and Econometrics7% of their works
  4. 4Nephrology5% of their works
  5. 5Infectious Diseases5% of their works
  6. 6Pulmonary and Respiratory Medicine4% of their works

Research topics

Which keywords describe Mark H. Rozenbaum's research?

The keywords of their largest research topics: Epidemiology, Community-Acquired Pneumonia, Pneumococcal Conjugate Vaccine, Human Metapneumovirus, Respiratory Syncytial Virus, Cardiac Amyloidosis, Transthyretin and Pathogenesis.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 18 words, with their numbers
  1. Epidemiology1084 topics
  2. Community-Acquired Pneumonia471 topic
  3. Pneumococcal Conjugate Vaccine471 topic
  4. Human Metapneumovirus421 topic
  5. Respiratory Syncytial Virus421 topic
  6. Cardiac Amyloidosis231 topic
  7. Transthyretin231 topic
  8. Pathogenesis192 topics
  9. FGF23171 topic
  10. phosphate171 topic
  11. Causal Inference121 topic
  12. Propensity Score121 topic
  13. Cost-effectiveness Analysis111 topic
  14. Quality of Life111 topic
  15. Influenza101 topic
  16. Virus101 topic
  17. Bacterial Meningitis91 topic
  18. Neisseria meningitidis91 topic

Where does Mark H. Rozenbaum work?

Mark H. Rozenbaum's main affiliation in the publication record is Pfizer (Netherlands), Netherlands.

How many publications and citations does Mark H. Rozenbaum have?

OpenAlex counts 119 works and 2,640 citations for Mark H. Rozenbaum, an h-index of 30, ranking #831,288 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Mark H. Rozenbaum. Posts are plain text and can be reported.